Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 25(18)2024 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-39337302

RESUMO

The protein S100B is a part of the S100 protein family, which consists of at least 25 calcium-binding proteins. S100B is highly conserved across different species, supporting important biological functions. The protein was shown to play a role in gut microbiota eubiosis and is secreted in human breast milk, suggesting a physiological trophic function in newborn development. This study explores the possible presence of the S100B motif in plant genomes, and of S100B-like immunoreactive material in different plant extracts, opening up potential botanical uses for dietary supplementation. To explore the presence of the S100B motif in plants, a bioinformatic workflow was used. In addition, the immunoreactivity of S100B from vegetable and fruit samples was tested using an ELISA assay. The S100B motif was expected in silico in the genome of different edible plants belonging to the Viridiplantae clade, such as Durio zibethinus or Malus domestica and other medicinal species. S100B-like immunoreactive material was also detected in samples from fruits or leaves. The finding of S100B-like molecules in plants sheds new light on their role in phylogenesis and in the food chain. This study lays the foundation to elucidate the possible beneficial effects of plants or derivatives containing the S100B-like principle and their potential use in nutraceuticals.


Assuntos
Suplementos Nutricionais , Alimento Funcional , Plantas Comestíveis , Subunidade beta da Proteína Ligante de Cálcio S100 , Subunidade beta da Proteína Ligante de Cálcio S100/metabolismo , Plantas Comestíveis/química , Simulação por Computador , Motivos de Aminoácidos , Fitoterapia/métodos , Biologia Computacional/métodos , Humanos , Frutas/química , Frutas/metabolismo , Filogenia , Proteínas de Plantas/metabolismo
2.
Sports (Basel) ; 12(8)2024 Aug 14.
Artigo em Inglês | MEDLINE | ID: mdl-39195597

RESUMO

BACKGROUND: Intense exercise during training requires dietary modulation to support health and performance and differs in different types of activities. Diet, supplementation with prebiotics and probiotics, and, more recently, even physical activity can potentially improve health outcomes by modifying and protecting the gut microbiota. A systematic review and meta-analysis were conducted to investigate the modulation of gut microbiota in different types and intensities of physical activity and different lifestyles of athletes. METHODS: The systematic review and meta-analysis were conducted according to the PRISMA guidelines, and the protocol was registered in PROSPERO (CRD42024500826). RESULTS: Out of 1318 studies, only 10 met the criteria for inclusion in the meta-analysis. The pilot study's meta-regression analysis highlights the role of type and intensity of exercise in changing the B/B (Bacillota/Bacteroidota) ratio (p = 0.001). CONCLUSIONS: As gut training becomes more popular among athletes, it is necessary to map interactions between microbiota and different types of physical activity, personalized diets, physical activities, and ergogenic supplements to enhance performance and athletic wellness.

3.
Healthcare (Basel) ; 12(6)2024 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-38540634

RESUMO

Digital technologies have greatly developed and impacted several aspects of life, including health and lifestyle. Activity tracking, mobile applications, and devices may also provide messages and goals to motivate adopting healthy behaviors, namely physical activity and dietary changes. This review aimed to assess the effectiveness of digital resources in supporting behavior changes, and thus influencing weight loss, in people with overweight or obesity. A systematic review was conducted according to the PRISMA guidelines. The protocol was registered in PROSPERO (CRD42023403364). Randomized Controlled Trials published from the database's inception to 8 November 2023 and focused on digital-based technologies aimed at increasing physical activity for the purpose of weight loss, with or without changes in diet, were considered eligible. In total, 1762 studies were retrieved and 31 met the inclusion criteria. Although they differed in the type of technology used and in their design, two-thirds of the studies reported significantly greater weight loss among electronic device users than controls. Many of these studies reported tailored or specialist-guided interventions. The use of digital technologies may be useful to support weight-loss interventions for people with overweight or obesity. Personalized feedback can increase the effectiveness of new technologies in motivating behavior changes.

4.
Int J Mol Sci ; 24(24)2023 Dec 13.
Artigo em Inglês | MEDLINE | ID: mdl-38139256

RESUMO

Inborn errors of metabolism (IEMs) comprise a diverse group of monogenic disorders caused by enzyme deficiencies that result either in a toxic accumulation of metabolic intermediates or a shortage of essential end-products. Certain IEMs, like phenylketonuria (PKU), necessitate stringent dietary intervention that could lead to microbiome dysbiosis, thereby exacerbating the clinical phenotype. The objective of this systematic review was to examine the impact of PKU therapies on the intestinal microbiota. This research was conducted following the PRISMA Statement, with data from PubMed, Scopus, ScienceDirect, and Web of Science. A total of 18 articles meeting the inclusion criteria were published from 2011 to 2022. Significant reductions in several taxonomic groups in individuals with PKU when compared to the control group were detected in a quantitative analysis conducted across seven studies. The meta-analysis synthesis indicates a contrast in biodiversity between PKU subjects and the control population. Additionally, the meta-regression results, derived from the Bacillota/Bacteroidota ratio data, suggest a potential influence of diet in adult PKU populations (p = 0.004). It is worth noting that the limited number of studies calls for further research and analysis in this area. Our findings indicate the necessity of enhancing understanding of microbiota variability in reaction to treatments among PKU subjects to design tailored therapeutic and nutritional interventions to prevent complications resulting from microbiota disruption.


Assuntos
Microbioma Gastrointestinal , Fenilcetonúrias , Adulto , Humanos , Fenilcetonúrias/complicações , Dieta
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA